5th Precision Medicine & Biomarkers Summit
September 13-14, 2018
Holiday Inn Munich City Centre | Munich, Germany登録
Mass cytometry yields new insights into systems biology by dramatically increasing the amount of information obtained from each cell. The Helios™ system provides a robust way to measure over 40 protein parameters per single cell using proven CyTOF® technology.
Join us for this compelling presentation.
Advancing Immuno-Oncology and CDx
|Date:||Friday, 14 September
|Venue:||Holiday In Munich City Centre
Senior Marketing Manager, EMEA, Fluidigm
|A Brief Introduction to Mass Cytometry|
|Shahram Kordasti, MD, PhD
Senior Lecturer, KHP-CRUK Cancer Centre
|Bench to Bytes: Translating Big Data to the Clinic|
In this session, Dr. Shahram Kordasti from King’s Health Partners-Cancer Research UK Cancer Centre will share his results using mass cytometry and multidimensional data analysis to identify two distinct subpopulations of regulatory T cells (Treg A and Treg B) with distinct phenotypes, gene expression, expandability and function in patients with aplastic anemia (AA) and myelodysplastic syndrome (MDS). This approach also identifies an immune signature that is predictive of response to immunotherapy at the time of diagnosis of AA or MDS, which may allow a more patient-specific approach to future treatment decisions.
Visit us at the Fluidigm Stand to learn more.
September 13–14, 2018
For Research Use Only. Not for use in diagnostic procedures.